1. How Manufacturer Copay Assistance Cards Actually Work
Both Eli Lilly (maker of Zepbound) and Novo Nordisk (maker of Wegovy and Saxenda) provide commercial copay cards designed to reduce out-of-pocket friction for patients. However, how much you actually pay depends entirely on whether your health plan covers the drug on its formulary:
As Low as $25 / Month
If your commercial health plan includes anti-obesity medications on its formulary and approves your Prior Authorization (PA), the card acts as secondary insurance. It pays up to $150–$225 of your remaining copay each month, subject to annual program maximums ($1,800–$2,100 per calendar year).
$550 – $650 / Month
If your employer has explicitly excluded weight management medications from your benefit design, the card provides a partial subsidy off the full list price (~$1,060 to $1,349/month). While substantially discounted, you must still budget $550+ monthly out-of-pocket.